Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113354623A reveals a novel thiourea dioxide reduction route for ilaprazole intermediates, offering superior purity and cost efficiency for API manufacturing.
Novel room-temperature method using metal triflates. High yield, recyclable catalyst, green solvents. Ideal for pharma intermediates.
Novel diisopropylamine environment method for phenanthrene compounds. High yield, scalable process for pharmaceutical intermediates. Reliable supply chain partner.
Patent CN109666044B discloses rigid [2.2]paracyclophane ligands enabling efficient asymmetric catalysis with scalable synthesis routes for industrial applications.
Patent CN112409235A details a Rh-catalyzed asymmetric hydrogenation route for chiral 4-halogenated tryptophan derivatives with 99.9% ee, offering a scalable solution for API intermediates.
Patent CN113789527B reveals a metal-free electrochemical route for aromatic amines, offering green synthesis and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN101817830B details a cost-effective FeCl3-catalyzed route for coumestan derivatives, offering significant supply chain advantages for pharmaceutical intermediate manufacturers.
Patent CN101921229B details a novel asymmetric catalytic hydrogenation route for L-Stepholidine. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Novel photocatalytic synthesis for bicyclo pentane derivatives. Efficient C-sp3-C-sp2 coupling. Cost-effective supply chain solution for pharma intermediates.
Advanced synthesis of 4-chloro-2H-chromene derivatives using BTC/DMF. Eliminates phosphorus pollution, ensures high purity, and offers scalable manufacturing for pharmaceutical intermediates.
Novel visible-light method for iodo-bicyclo[1.1.1]pentane derivatives. Cost-effective, catalyst-free process ensuring high purity and supply chain reliability for pharmaceutical intermediates.
Patent CN118754905B reveals nickel catalysis for silane synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Novel 3,5-dialkyl pyrazole ligand enables C-Cl greater than C-OTf selectivity in Buchwald-Hartwig reactions, offering cost-effective pharma intermediate synthesis.
Patent CN108299413A enables metal-free synthesis of benzoxazoles. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel sulfur-halogen process enhances purity and scalability for GLP-1 agonist intermediates, offering significant supply chain stability and cost reduction benefits for global buyers.
Patent CN104072430B reveals catalyst-free synthesis for high-purity triazolidine derivatives ensuring cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110372544B details a cost-effective iron-titanium catalytic system for biaryl synthesis, offering significant supply chain stability and reduced environmental impact.
Novel synthesis route for tetrahydroprotoberberine compounds via Bischler-Napieralski reaction. Enables batch production of l-SPD and d-SPD with high optical purity.
Patent CN117776885A reveals a palladium-catalyzed route for alpha-tertiary ethers. This method offers high yield and mild conditions for scalable pharmaceutical intermediates manufacturing.
Discover the novel synthesis of Valsartan via Patent CN100522953C. This route eliminates toxic tin azides, ensuring high optical purity and cost-effective manufacturing for global supply chains.